Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections.

Hepatitis C virus (HCV) infections are emerging as one of the foremost challenges in healthcare owing to its chronicity and the virus's quasispecies nature. Worldwide, over 170 million people are chronically infected with HCV, with an annual mortality of over 500,000 people across the world. The emerging pathophysiological evidence links HCV infections to a risk of developing liver diseases such as cirrhosis and hepatocellular carcinoma.

Correction: (Sw.), DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: and investigations.

[This corrects the article DOI: 10.18632/oncotarget.25717.

(Sw.), DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: and investigations.

Plant originated drugs/formulations are extensively prescribed by the physicians as a complementary therapy for treating various human ailments including cancer. In this study leaves methanol extract was prepared and exposed to human breast cancer cell lines i.e.

Epidemiology of viral hepatitis B and C infections in ibb city, yemen.

Background: The global epidemic of hepatitis B and hepatitis C is a serious publichealth problem. Chronic hepatitis B and hepatitis C are among the leading causes of preventable death worldwide. World Health Organization (WHO) estimates that up to two billion people in the world have been infected with HBV; about 350 million people live with chronic HBV infection, and about 600,000 people die from HBV- related liver disease or HCC each year.